1. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC;Antonia;New Engl J Med,2018
2. Network NCC. Non-Small Cell Lung Cancer (Version 3. 2020). Available at https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed February 16, 2020.
3. Hui R, Özgüroğlu M, Villegas A, et al. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Lancet Oncol.
4. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study;Hui;Lancet Oncol,2019
5. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma;Machtay;J Thorac Oncol,2012